Strategy & Corporate DevelopmentEvent: September 3, 2026
Galino Labs noted that Pfizer acquired a CD228 asset for Medicus Pharma Ltd.
Published
Signal category
Strategy & Corporate Development
Quote
“Another one for Pfizer... and it makes you wonder how this CD228 asset (a first for this target) will work out for Medicus Pharma Ltd.”
— Thanos Tsagkadouras|Galino Labs team
Company
Galino Labs
Designing the future of medicine through bio-strategy & decision analysis
- Industry
- Business Consulting and Services
- Company size
- 1 employees
Life sciences leaders face analysis paralysis, risk aversion, and cognitive overload, especially when navigating M&A, pipeline prioritization, or commercial pivots. At Galino Labs, we equip biotech CEOs, investors, and scientific leaders with the strategic clarity, cognitive tools, and deal-making edge needed to thrive in an industry where uncertainty is the only constant.